about
Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition.Early-onset of ADCK4 glomerulopathy with renal failure: a case report.Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage.Podocytes: the Weakest Link in Diabetic Kidney Disease?The next generation of therapeutics for chronic kidney diseaseThe long noncoding RNA Tug1 connects metabolic changes with kidney disease in podocytesCoenzyme Q10 supplementation therapy for 2 children with proteinuria renal disease and ADCK4 mutation: Case reports and literature review.Steroid-resistant nephrotic syndrome caused by co-inheritance of mutations at NPHS1 and ADCK4 genes in two Chinese siblings.
P2860
Q34994550-9B53E682-D32D-4366-B317-D3C618D08A49Q36309546-1291CA27-928D-45F3-A219-4CD6E95CE58FQ37052056-E1DEEEE4-2EC8-4658-AF86-7C078BD9BA51Q37340690-4E52706F-7620-47F5-A979-2E4EC3FC09B8Q38845590-6B4E264C-3379-46C6-BE9E-933465CED8FAQ42734485-B3E3B6C5-261D-4CC6-B25B-D1936D28F5BDQ47134250-90641B81-9086-48B2-BE30-09F7C0D902CAQ49469264-B3ADA32D-4468-44FF-B13D-78BE5FE04235
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
ADCK4 "reenergizes" nephrotic syndrome.
@en
ADCK4 "reenergizes" nephrotic syndrome.
@nl
type
label
ADCK4 "reenergizes" nephrotic syndrome.
@en
ADCK4 "reenergizes" nephrotic syndrome.
@nl
prefLabel
ADCK4 "reenergizes" nephrotic syndrome.
@en
ADCK4 "reenergizes" nephrotic syndrome.
@nl
P2860
P356
P1476
ADCK4 "reenergizes" nephrotic syndrome.
@en
P2860
P304
P356
10.1172/JCI73168
P407
P577
2013-11-25T00:00:00Z